Skip to main content

Main menu

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

INTRODUCTION

E. D. Bateman
European Respiratory Review 2005 14: 83; DOI: 10.1183/09059180.05.00009600
E. D. Bateman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

In the management of chronic obstructive pulmonary disease (COPD), achieving sustained bronchodilation through the regular use of long-acting bronchodilators is currently the best treatment option for symptomatic patients. Delivery of these drugs via inhalation therefore needs to be adequate and reliable to maximise the benefits of such treatment. However, current treatment guidelines contain little advice on the key elements of inhalation therapy; namely, delivery devices and their performance in COPD, approaching inhaler selection, methods for improving compliance and the impact of patient preference on drug delivery and treatment outcomes.

To explore this topic in more detail, a Round Table meeting, sponsored by Boehringer Ingelheim GmbH, was held in Zürich, Switzerland, on 3–4 June 2005. The papers in this Review arise from the proceedings of that meeting. Our purpose was to consider the subject of inhaler use and selection in COPD, and how compliance and treatment outcomes might be improved by taking patient preference into account. Our discussion was broken down into the following categories: patient needs and medication styles [1]; communication between patient and doctor [2]; adherence to therapy [3]; advantages and disadvantages of the main types of inhaler devices and how they affect technique [4]; assessment of device preference and satisfaction [5]; and the role of the caregiver in choosing the inhaler device [6]. A summary of the points from each paper is provided below.

    • © ERSJ Ltd

    References

    1. ↵
      Osman LM, Hyland ME. Patient needs and medication styles in COPD. Eur Respir Rev 2005; 14: 89–92.
      OpenUrlCrossRef
    2. ↵
      Booker R. Effective communication with the patient. Eur Respir Rev 2005; 14: 93–96.
      OpenUrlCrossRef
    3. ↵
      Rand CS. Patient adherence with COPD therapy. Eur Respir Rev 2005; 14: 97–101.
    4. ↵
      Newman SP. Inhaler treatment options in COPD. Eur Respir Rev 2005; 14: 102–108.
      OpenUrl
    5. ↵
      Anderson P. Patient preference for and satisfaction with inhaler devices. Eur Respir Rev 2005; 14: 109–116.
      OpenUrl
    6. ↵
      Chapman KR, Voshaar TH, Virchow JC. Inhaler choice in primary practice. Eur Respir Rev 2005; 14: 117–122.
    PreviousNext
    Back to top
    View this article with LENS
    Vol 14 Issue 96 Table of Contents
    • Table of Contents
    • Index by author
    Email

    Thank you for your interest in spreading the word on European Respiratory Society .

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    INTRODUCTION
    (Your Name) has sent you a message from European Respiratory Society
    (Your Name) thought you would like to see the European Respiratory Society web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Print
    Citation Tools
    INTRODUCTION
    E. D. Bateman
    European Respiratory Review Dec 2005, 14 (96) 83; DOI: 10.1183/09059180.05.00009600

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero

    Share
    INTRODUCTION
    E. D. Bateman
    European Respiratory Review Dec 2005, 14 (96) 83; DOI: 10.1183/09059180.05.00009600
    del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
    Full Text (PDF)

    Jump To

    • Article
      • References
    • Info & Metrics
    • PDF
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    More in this TOC Section

    • Smoking cessation: a clinical update
    • Elucidating the causes and examining the latest clinical findings in pulmonary fibrosis
    • Winners of the ERS Annual Awards 2007
    Show more Introduction

    Related Articles

    Navigate

    • Home
    • Current issue
    • Archive

    About the ERR

    • Journal information
    • Editorial board
    • Press
    • Permissions and reprints
    • Advertising
    • Sponsorship

    The European Respiratory Society

    • Society home
    • myERS
    • Privacy policy
    • Accessibility

    ERS publications

    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS books online
    • ERS Bookshop

    Help

    • Feedback

    For authors

    • Instructions for authors
    • Publication ethics and malpractice
    • Submit a manuscript

    For readers

    • Alerts
    • Subjects
    • RSS

    Subscriptions

    • Accessing the ERS publications

    Contact us

    European Respiratory Society
    442 Glossop Road
    Sheffield S10 2PX
    United Kingdom
    Tel: +44 114 2672860
    Email: journals@ersnet.org

    ISSN

    Print ISSN: 0905-9180
    Online ISSN: 1600-0617

    Copyright © 2023 by the European Respiratory Society